发布求助
文献互助 智能选刊 最新文献

InFo Hämatologie + Onkologie最新文献

筛选
英文 中文
Neues zu CAR-T-Zellen und GvHD 有关 CAR-T 细胞和 GvHD 的新闻
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0598-x
Miriam Sonnet
{"title":"Neues zu CAR-T-Zellen und GvHD","authors":"Miriam Sonnet","doi":"10.1007/s15004-024-0598-x","DOIUrl":"https://doi.org/10.1007/s15004-024-0598-x","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"18 8","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141049809","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stabiles PI-RADS 3 benötigt wohl zunächst keine Folgebiopsie 稳定的 PI-RADS 3 可能最初不需要进行随访活检
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0602-5
Robert Bublak
{"title":"Stabiles PI-RADS 3 benötigt wohl zunächst keine Folgebiopsie","authors":"Robert Bublak","doi":"10.1007/s15004-024-0602-5","DOIUrl":"https://doi.org/10.1007/s15004-024-0602-5","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"69 5","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141038689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Aktuelle Daten zur Avelumab-Erhaltung 目前有关阿维列单抗维持治疗的数据
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0588-z
Elke Engels
{"title":"Aktuelle Daten zur Avelumab-Erhaltung","authors":"Elke Engels","doi":"10.1007/s15004-024-0588-z","DOIUrl":"https://doi.org/10.1007/s15004-024-0588-z","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"11 2","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141035968","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adjuvant gemäß dem individuellen Risiko therapieren 根据个体风险进行辅助治疗
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0593-2
Mascha Pömmerl
{"title":"Adjuvant gemäß dem individuellen Risiko therapieren","authors":"Mascha Pömmerl","doi":"10.1007/s15004-024-0593-2","DOIUrl":"https://doi.org/10.1007/s15004-024-0593-2","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"28 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141057753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
15-Jahres-Ergebnisse der ProtecT-Studie ProtecT 15 年研究结果
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0579-0
S. Spohn, A. Grosu
{"title":"15-Jahres-Ergebnisse der ProtecT-Studie","authors":"S. Spohn, A. Grosu","doi":"10.1007/s15004-024-0579-0","DOIUrl":"https://doi.org/10.1007/s15004-024-0579-0","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"17 4","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141036522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TUR-P während akuter Prostatitis? 在急性前列腺炎期间进行 TUR-P？
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0583-4
M. Greiff
{"title":"TUR-P während akuter Prostatitis?","authors":"M. Greiff","doi":"10.1007/s15004-024-0583-4","DOIUrl":"https://doi.org/10.1007/s15004-024-0583-4","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"13 7","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141037730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Positive Empfehlung für Faktor-D-Inhibitor bei PNH 积极推荐使用因子 D 抑制剂治疗 PNH
InFo Hämatologie + Onkologie Pub Date : 2024-05-01 DOI: 10.1007/s15004-024-0591-4
{"title":"Positive Empfehlung für Faktor-D-Inhibitor bei PNH","authors":"","doi":"10.1007/s15004-024-0591-4","DOIUrl":"https://doi.org/10.1007/s15004-024-0591-4","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"1974 10","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141027785","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Malignom bei Screenings ignoriert 筛查中忽略的恶性肿瘤
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0562-9
M. Greiff
{"title":"Malignom bei Screenings ignoriert","authors":"M. Greiff","doi":"10.1007/s15004-024-0562-9","DOIUrl":"https://doi.org/10.1007/s15004-024-0562-9","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"154 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140756342","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Subkutane Therapieformulierungen 皮下治疗配方
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0546-9
M. Borchers
{"title":"Subkutane Therapieformulierungen","authors":"M. Borchers","doi":"10.1007/s15004-024-0546-9","DOIUrl":"https://doi.org/10.1007/s15004-024-0546-9","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"213 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140776086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mehr Gehalt für MFA 艺术硕士的更多薪酬
InFo Hämatologie + Onkologie Pub Date : 2024-04-01 DOI: 10.1007/s15004-024-0563-8
Matthias Wallenfels
{"title":"Mehr Gehalt für MFA","authors":"Matthias Wallenfels","doi":"10.1007/s15004-024-0563-8","DOIUrl":"https://doi.org/10.1007/s15004-024-0563-8","url":null,"abstract":"","PeriodicalId":503002,"journal":{"name":"InFo Hämatologie + Onkologie","volume":"379 3","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140781237","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：604180095
Book学术官方微信
小红书